SI1812058T1 - Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo - Google Patents

Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo

Info

Publication number
SI1812058T1
SI1812058T1 SI200531580T SI200531580T SI1812058T1 SI 1812058 T1 SI1812058 T1 SI 1812058T1 SI 200531580 T SI200531580 T SI 200531580T SI 200531580 T SI200531580 T SI 200531580T SI 1812058 T1 SI1812058 T1 SI 1812058T1
Authority
SI
Slovenia
Prior art keywords
vaccine
chlamydia trachomatis
diagnostic use
trachomatis antigens
antigens
Prior art date
Application number
SI200531580T
Other languages
English (en)
Inventor
Michael Theisen
Anja Olsen
Robert Leah
Frank Follmann
Klaus Jensen
Peter Andersen
Original Assignee
Statens Serum Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Serum Institut filed Critical Statens Serum Institut
Publication of SI1812058T1 publication Critical patent/SI1812058T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200531580T 2004-10-25 2005-10-11 Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo SI1812058T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200401633 2004-10-25
DKPA200501069 2005-07-19
PCT/DK2005/000651 WO2006045308A2 (en) 2004-10-25 2005-10-11 Chlamydia trachomatis antigens for vaccine and diagnostic use
EP05790937A EP1812058B1 (en) 2004-10-25 2005-10-11 Chlamydia trachomatis antigens for vaccine and diagnostic use

Publications (1)

Publication Number Publication Date
SI1812058T1 true SI1812058T1 (sl) 2013-02-28

Family

ID=35686446

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531580T SI1812058T1 (sl) 2004-10-25 2005-10-11 Antigeni chlamidia trachomatis za cepivo in diagnostiäśno rabo

Country Status (11)

Country Link
US (1) US8889142B2 (sl)
EP (3) EP2269636A3 (sl)
JP (3) JP5024830B2 (sl)
CA (2) CA2585011C (sl)
CY (1) CY1113601T1 (sl)
DK (1) DK1812058T3 (sl)
ES (1) ES2389562T3 (sl)
PL (1) PL1812058T3 (sl)
PT (1) PT1812058E (sl)
SI (1) SI1812058T1 (sl)
WO (1) WO2006045308A2 (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
US8541007B2 (en) 2005-03-31 2013-09-24 Glaxosmithkline Biologicals S.A. Vaccines against chlamydial infection
CA2608278A1 (en) * 2005-05-12 2006-12-28 Guido Grandi Immunogenic compositions for chlamydia trachomatis
WO2007082105A2 (en) * 2006-01-16 2007-07-19 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Chlamydia vaccine
EP1970708A1 (de) * 2007-03-07 2008-09-17 Mikrogen Molekularbiologische Entwicklungs-GmbH Biochip und Verfahren zum selektiven Nachweis von Chlamydia trachomatis-Infektionen
AU2008246064A1 (en) 2007-05-01 2008-11-06 The Board Of Regents Of The University Of Texas System Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
WO2010027442A1 (en) * 2008-08-26 2010-03-11 Becton, Dickinson And Company Assay for chlamydia trachomatis by amplification and detection of chlamydia trachomatis cytotoxin gene
US9068007B2 (en) 2008-10-09 2015-06-30 Board Of Regents, The University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
DK2907523T3 (en) * 2009-01-29 2018-07-16 British Columbia Cancer Agency Branch COMPOSITIONS COMPREHENSIVE KLAMYDIA ANTIGENES.
ES2555858T3 (es) * 2009-03-24 2016-01-11 Transgene Sa Biomarcador para el control de pacientes
WO2011063133A1 (en) * 2009-11-18 2011-05-26 Auburn University LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE
WO2011112670A2 (en) * 2010-03-09 2011-09-15 Board Of Regents, University Of Texas System Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
US8735543B2 (en) 2010-05-28 2014-05-27 Spixia Biotechnology Ab Chimeric MOMP antigen
JP2013545448A (ja) * 2010-10-20 2013-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド クラミジア抗原及びその使用
US20150010591A1 (en) * 2011-09-30 2015-01-08 The University Of British Columbia Chlamydia antigen compositions and uses thereof
US9827319B2 (en) 2012-05-29 2017-11-28 The Research Foundation For The State University Of New York Combined therapy and prophylaxis for genital tract infections
ITNA20120046A1 (it) * 2012-08-02 2014-02-03 No Self S R L Uso di acidi nucleici di sistemi biologici parassiti, patogeni e infestanti per l'inibizione e/o controllo degli stessi sistemi
AU2014234765B2 (en) 2013-03-18 2018-01-25 Statens Serum Institut Vaccines against Chlamydia sp.
WO2015106345A1 (en) 2014-01-16 2015-07-23 Mcmaster University Type iii secretion injectisome proteins for treatment and prevention of chlamydial infections
NL2022581B1 (en) * 2019-02-14 2020-08-27 Koppert Bv Composition comprising a mixture of dna molecules, uses thereof as biological inhibitor and method for production
CN117106078A (zh) * 2023-07-18 2023-11-24 华南农业大学 一种水稻橙叶植原体抗原膜蛋白多克隆抗体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
GB9626864D0 (en) * 1996-12-24 1997-02-12 Smithkline Beecham Biolog Vaccine
DK0832093T3 (da) 1995-06-07 2007-01-08 Sanofi Pasteur Inc Udtrykkelse af lipoproteiner
US6136958A (en) 1996-09-30 2000-10-24 Genentech, Inc. Antibodies to vertebrate smoothened proteins
EP0892061A3 (en) 1997-07-18 1999-02-24 Smithkline Beecham Corporation The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
EP1032674B1 (en) * 1997-11-21 2007-01-24 Serono Genetics Institute S.A. (chlamydia pneumoniae) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
AU754264B2 (en) * 1997-11-28 2002-11-07 Genset S.A. Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
US6919187B2 (en) 2000-04-21 2005-07-19 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US6736222B2 (en) 2001-11-05 2004-05-18 Vector Magnetics, Llc Relative drill bit direction measurement
EP2168596B1 (en) * 2001-12-12 2012-05-23 Novartis Vaccines and Diagnostics S.r.l. Immunisation against chlamydia trachomatis
ATE478091T1 (de) * 2003-02-24 2010-09-15 Pasteur Institut Anwendung des cpn104 polypeptids aus chlamydia pneumoniae oder dessen antikörper zur diagnose einer chlamydia infektion
US20100255002A1 (en) * 2003-06-26 2010-10-07 Chiron Corporation Immunogenic compositions for chlamydia trachomatis
US20090028891A1 (en) * 2004-11-11 2009-01-29 Queensland University Of Technology Chlamydia Antigens and Uses Thereof

Also Published As

Publication number Publication date
CA2585011A1 (en) 2006-05-04
JP2012102108A (ja) 2012-05-31
EP2269636A3 (en) 2011-04-06
JP2008520550A (ja) 2008-06-19
US8889142B2 (en) 2014-11-18
PL1812058T3 (pl) 2012-11-30
PT1812058E (pt) 2012-09-17
CA2585011C (en) 2014-02-18
WO2006045308A2 (en) 2006-05-04
EP2314314A2 (en) 2011-04-27
CY1113601T1 (el) 2016-06-22
EP2269636A2 (en) 2011-01-05
JP5024830B2 (ja) 2012-09-12
EP1812058A2 (en) 2007-08-01
EP2314314A3 (en) 2011-05-11
CA2820140A1 (en) 2006-05-04
WO2006045308A3 (en) 2006-12-07
EP1812058B1 (en) 2012-06-13
WO2006045308A8 (en) 2011-08-11
ES2389562T3 (es) 2012-10-29
JP2013231050A (ja) 2013-11-14
DK1812058T3 (da) 2012-09-17
US20090304722A1 (en) 2009-12-10

Similar Documents

Publication Publication Date Title
PL1812058T3 (pl) Antygeny Chlamydia trachomatis do stosowania w szczepionkach i diagnostyce
TWI365191B (en) Vaccine
EP1804831A4 (en) VACCINES BASED ON LLO AND LISTERIA
EP2097534A4 (en) HUMAN ANTIBODIES BINDING TO CD70 AND USES THEREOF
ZA200704908B (en) IL-15 Antigen Arrays and uses thereof
ZA200707339B (en) Human antibodies against rabies and uses thereof
EP1874217A4 (en) DEVICE AND METHOD FOR ENDOSCOPIC ANNULOPLASTY
HK1109036A1 (en) Reclining device
ZA200904657B (en) Human antibodies that bind CD70 and uses thereof
GB0409940D0 (en) Vaccine
IL187479A0 (en) Antigen conjugates and uses thereof
EP1812055A4 (en) CHLAMYDIEN-ANTIGENE AND ITS USES
ZA200608278B (en) Stabilised TAT Antigen and the use thereof for anit-HIV Vaccination
GB0411150D0 (en) Vaccine
ZA200801874B (en) Antigenic peptides and their use
ZA200803664B (en) Chimeric antigens and vaccines
GB0508011D0 (en) Intra-vaginal device
GB0413510D0 (en) Vaccine
SG119341A1 (en) Novel bacterium and vaccine
GB0412407D0 (en) Vaccine
GB0428381D0 (en) Vaccine
IL178276A0 (en) Dimeric tat antigen and the use thereof for anti-hiv vaccination
ZA200805298B (en) Conjugate vaccines
GB0406598D0 (en) Vaccine
GB0419918D0 (en) Vaccine